Skip to main content

Stryker Corporation Q3 FY2026 results

  • SYK · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$309.64−0.88%Close 13 Nov 2026

Stryker Corporation reported revenue of $6.52 billion, up 7.6% from a year earlier, net income of $753 million and diluted earnings per share of $1.96 against $2.22 for the third quarter of fiscal 2026 (the three months to 30 Sep 2026).

From its quarterly report, the results first announced on 29 Oct 2026. Compiled and checked by AapWire.

Q3 FY2026 against Q3 FY2025

Three months to 30 Sep 2026, against the three months to 30 Sep 2025. Amounts in USD.

Stryker Corporation Q3 FY2026 results against the year-ago quarter
MeasureQ3 FY2026Q3 FY2025Change
Revenue$6.52B$6.06B+7.6%
Gross profit$4.25B$3.85B+10.3%
Gross margin65.2%63.6%+1.6 pts
Operating income$1.03B$1.14B−8.9%
Operating margin15.9%18.7%−2.9 pts
Net income$753.0M$859.0M−12.3%
Diluted EPS$1.96$2.22−11.7%
Operating cash flow$1.46B$1.54B−5.1%
Capital expenditure$237.0M$187.0M+26.7%
Free cash flow$1.22B$1.35B−9.5%

Operating KPIs for the quarter

Stryker Corporation operating KPIs, Q3 FY2026
KPIQ3 FY2026Change on a year
Organic net sales (change on a year)7.7%down 1.8 points
Neuro Cranial Instruments revenue$670.0Mup 5.2%
Orthopaedic Instruments revenue$535.0Mup 8.7%
Enabling Technologies revenue$28.0Mdown 37.8%
Medical revenue$1.1Bup 9.7%
Endoscopy revenue$1.0Bup 14.0%
Trauma and Extremities revenue$1.0Bup 5.2%
Instruments revenue$996.0Mup 5.0%
Ortho Tech revenue$754.0Mup 15.8%
Knees revenue$635.0Mup 1.1%
Vascular revenue$566.0Mup 7.8%
Hips revenue$453.0Mdown 0.9%
Spinal Implants revenue$4.0Mdown 33.3%
MedSurg and Neurotechnology (revenue)$3.7Bup 9.2%
Orthopaedics (revenue)$2.9Bup 5.7%
United States revenue$5.0Bup 8.3%
International revenue$1.6Bup 5.7%

Earlier quarters

Stryker Corporation results, last eight filed quarters
QuarterPeriod endRevenueChange on a yearDiluted EPS
Q3 FY202630 Sep 2026$6.52B+7.6%$1.96
Q2 FY202630 Jun 2026$6.59B+9.4%$3.30
Q1 FY202631 Mar 2026$6.02B+2.6%$1.93
Q4 FY202531 Dec 2025$7.17B+11.4%$2.20
Q3 FY202530 Sep 2025$6.06B+10.2%$2.22
Q2 FY202530 Jun 2025$6.02B+11.1%$2.29
Q1 FY202531 Mar 2025$5.87B+11.9%$1.69
Q4 FY202431 Dec 2024$6.44B+10.7%$1.41

More on Stryker Corporation: financial statements · revenue · earnings per share

SYK's results, as they are filed.

Releases read within minutes, guidance against results, the quarter in its eight-quarter history, and an alert on each new report.